OGEN vs MSFT: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

MSFT has stronger fundamentals based on our AI analysis.

OGEN
ORAGENICS INC
STRONG SELL
92%
Confidence
VS
MSFT
MICROSOFT CORP
BUY
91%
Confidence

OGEN vs MSFT Fundamental Comparison

Metric OGEN MSFT
Revenue $37,653.0 $158.9B
Net Income $-9.8M $66.2B
Net Margin -26,140.0% 41.7%
ROE -118.9% 16.9%
ROA -97.8% 10.0%
Current Ratio 5.60x 1.39x
Debt/Equity 0.00x 0.10x
EPS $-4.56 $8.87

Green = Better metric | Red = Weaker metric

View Full OGEN Analysis →
View Full MSFT Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

OGEN vs AAPL MSFT vs GOOGL OGEN vs AMZN MSFT vs NVDA

OGEN vs MSFT: Frequently Asked Questions

Is OGEN or MSFT a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. OGEN is rated STRONG SELL (92% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.

How does OGEN compare to MSFT fundamentally?

ORAGENICS INC has ROE of -118.9% vs MICROSOFT CORP's 16.9%. Net margins are -26,140.0% vs 41.7% respectively.

Which stock pays higher dividends, OGEN or MSFT?

OGEN has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in OGEN or MSFT for long term?

For long-term investing, consider that OGEN has STRONG SELL rating with 92% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about OGEN vs MSFT?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OGEN vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.